Navigation Links
Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate) for Treatment of Osteoarthritis
Date:9/26/2011

PARSIPPANY, N.J., Sept. 26, 2011 /PRNewswire/ -- Fidia Farmaceutici S.p.A. ("Fidia") announced today that it has assumed responsibility for distributing and promoting the osteoarthritis (OA) treatment, Hyalgan (sodium hyaluronate), in the United States through its wholly-owned subsidiary, Fidia Pharma USA Inc. ("Fidia USA"). Fidia USA has engaged Interpace BioPharma, LLC. ("Interpace") to provide commercialization services to support Hyalgan.

Hyalgan was introduced in Italy in 1987. In 1997, Hyalgan became the first viscosupplementation product approved for marketing by the U.S. Food and Drug Administration.  More than 38 million doses of Hyalgan have been administered worldwide since its introduction.(1) Hyalgan is indicated to relieve pain associated with osteoarthritis (OA) of the knee when simple analgesics like acetaminophen have failed.

"We are pleased to continue providing a treatment that has helped millions of patients worldwide who have suffered the debilitating effects of osteoarthritis," said Antonio Germani, CEO of Fidia Farmaceutici S.p.A.  "Hyalgan has demonstrated its safety and efficacy in more than 90 clinical trials involving more than 13,000 patients.  Our commitment is to provide our customers and patients the quality service they deserve, including reimbursement and patient assistance as well as patient education materials. Our goal is to see to it that Hyalgan remains a sustainable treatment of choice for patients with knee pain associated with OA," said Germani.

About Osteoarthritis (OA)

According to the Arthritis Foundation, 27 million Americans suffer from OA, which is common in all races and backgrounds.  The condition usually appears after the age of 45 years. Men under age 55 years are more likely to have osteoarthritis than women in the same age range.  After 55 years, women are more commonly affected.  OA is a chronic condition characterized by the breakdown of the j
'/>"/>

SOURCE Fidia Farmaceutici S.p.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HYALGAN® (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici S.p.A.
2. Obecure Executes Licensing and Clinical Supply Agreement With Farmaceutici-Formenti SPA for Extended Release Formulation of Betahistine
3. VWR International, LLC Acquires INTERNATIONAL P.B.I. S.p.A.
4. OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010
5. CareFusion Signs Exclusive Partnership Agreement With Minimally Invasive Devices to Distribute FloShield Laparoscopic Technology
6. Osteotechs MagniFuse(TM) Distributed to 68 U.S. Hospitals as Product Revenue Surpasses $1 Million
7. Par Obtains Exclusive Rights to Market and Distribute Generic Zetia(R) in the U.S.
8. Patient Advocacy Group Distributes Wallet Cards to Help Protect Patients from Medication Switching
9. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
10. Draeger Announces Partnership With L. N. Curtis & sons to Distribute Emergency Responder Equipment
11. As Cholera Outbreak Spreads, World Vision Deploys Teams to Distribute Emergency Health Supplies, Focus on Preventative Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... REDWOOD CITY, Calif. , May 1, 2015  AcelRx ... company focused on the development and commercialization of innovative ... today announced that Timothy E. Morris , chief ... events.  Details of the events are as follows: ... Tuesday, May 5 Location:  The Omni Berkshire Place, ...
(Date:4/30/2015)... MOUNTAIN VIEW, Calif., April 30, 2015 Omnicell, Inc. ... and supply management solutions to healthcare systems, today announced ... GAAP results: Revenue for the first quarter ... 14.2% from the first quarter of 2014, and down ... 2014. First quarter 2015 net income as ...
(Date:4/30/2015)... JOLLA, Calif. , April 30, 2015   ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended March ... U.S. financial markets close. Regulus will ... 7, 2015, at 5:00 pm Eastern Daylight Time to ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3
... 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ... candidate, has been granted orphan drug designation from the ... of pediatric Clostridium difficile infection (CDI).  This ... covers all formulations of fidaxomicin used to treat ...
... 2011 ULURU Inc. (NYSE Amex: ULU), ... a portfolio of wound management and oral care products, today ... 5,000,000 shares of its common stock at a price per ... an institutional investor, resulting in gross proceeds of approximately $500,000. ...
Cached Medicine Technology:Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 2Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 3Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 4ULURU Inc. to Raise $500,000 in Registered Direct Offering 2
(Date:5/2/2015)... (PRWEB) May 02, 2015 ProText Kinetic 2 ... use in Final Cut Pro X. ProText Kinetic 2 ... in Final Cut Pro X . Easily create ... with Pixel Film Studios' ProText Kinetic 2. , Using ProText ... by staggering two ProText Kinetic presets in the FCPX timeline. ...
(Date:5/2/2015)... 2015 Kare Visits LLC. launched in Chicago ... caregivers. Kare Visits offers relief for caregivers by visiting ... According to the Caregiver Action Network, eight in ... 20 hours a week caring for an elderly or disabled ... hire a nurse, a caregiver is now empowered to schedule ...
(Date:5/1/2015)... BWI (PRWEB) May 02, 2015 The ... It is http://www.thevenetiangracebay.com , and it is elegant ... the stunning white and attractive turquoise hues of Grace ... Google, sixty seven percent of leisure travelers used their ... that smartphones were used in the planning and researching ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 TROY Healthcare ... Cerner Southeast Regional User Group (RUG) Conference in Atlanta, ... Southeast Regional User Group Conference provides a forum for ... who support all aspects of electronic medical record operations, ... Cerner software applications. , In addition to sponsoring the ...
(Date:5/1/2015)... The Quail Creek Relay for Life Team raised over ... Quail Creek Relay team has raised almost $860,000. Quail ... including their biggest event, January’s Dinner and Auction; an annual ... Creek Relay for Life team was established to honor a ... states, “I was hooked when I learned how the money ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... being used more and more often to treat abdominal aortic ... ever older and sicker patients, the long-term survival of those ... two decades. This is shown in a major Swedish study ... findings are published in Circulation: Journal of the American ...
... 7 The Cystic Fibrosis Foundation announced today that all ... requiring that all newborns be screened for cystic fibrosis (CF) ... of cystic fibrosis, a life-threatening, genetic disease, can have a ... condition. , , Newborn screening for CF was adopted ...
... 7 Startech Environmental Corp. (OTC BB: STHK), a fully reporting, ... take any action with respect to the commencement of a tender ... purchase all of the outstanding shares of Startech for $0.65 per ... today said that it will carefully review the tender offer materials ...
... , NEWARK, N.J., July 7 BioNeutral Group, Inc. ... Science company announced today that independent laboratory testing performed ... are completely eliminated by the Company,s Ygiene(TM) Hospital Grade ... using the EPA required Fungicidal Use Dilution test, showed ...
... Fairfield County residents will have the opportunity to witness a ... the traditional lighting of the Saugatuck River Bridge at dusk. ... at the door, will enjoy cuisine and drink from some ... the chance to participate in a silent auction that includes ...
... July 7, 2009 AMERIGROUP Corporation (NYSE: AGP ... the second quarter ended June 30, 2009, at approximately 6:00 ... 8:30 a.m. Eastern Time on the same day, AMERIGROUP,s management ... and other information. , , To listen to the ...
Cached Medicine News:Health News:Operation for aneurysm yields nearly normal longevity 2Health News:All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 2Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 2Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 3Health News:Independent Laboratory Testing Shows BioNeutral's Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores 2Health News:Independent Laboratory Testing Shows BioNeutral's Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores 3Health News:Al's Angels' 'Angels in July' Saugatuck River Bridge Lighting to Benefit Children in Need 2Health News:AMERIGROUP Corporation to Discuss Second Quarter Earnings on July 31 2
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
... ADC drugs of abuse tests are highly accurate ... SAMHSA recommended cut-off as confirmed by GC/MS testing. ... more specific alternative method (such as GC/MS) must ... result. Professional judgment should be applied to any ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... quantitative microplate enzyme immunoassay that can identify bladder ... recurrence or occult disease. The test is performed ... twice as sensitive as urine cytology. Urologists can ... identifying those patients who may benefit from more ...
Medicine Products: